HH Biotechnology Holdings Company
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a HHBT research report →
About the company
HH Biotechnology Holdings Company operates within the health and green industries. Its primary activities include the cultivation and distribution of macadamia nuts, which are then utilized in a broad spectrum of products, including foodstuffs, culinary oils, wellness items, personal care products, and cosmetic formulations. The entity, originally established in 1987, was previously named Great China International Holdings, Inc.
- CEO
- Sheng Jiang
- IPO
- 2005
- Employees
- 121
- HQ
- Shenyang, CN
Price Chart
- Market Cap
- $1.41K
- P/E
- 0.00
- P/S
- 0.00
- P/B
- 0.00
- EV/EBITDA
- -0.95
- Div Yield
- 0.00%
- Gross Margin
- 29.45%
- Op Margin
- 38.78%
- Net Margin
- 30.99%
- ROE
- 8.78%
- ROIC
- -112.64%
- Revenue
- $7.99M · 0.00%
- Net Income
- $2.48M · 0.00%
- EPS
- $0.18 · 0.00%
- Op Income
- $3.10M
- FCF YoY
- 0.00%
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- 3.95
- Avg Volume
- 4.78K
Get TickerSpark's AI analysis on HHBT
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our HHBT coverage
Recent articles, reports, and earnings notes.
No research on HHBT yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate HHBT report →Similar companies
Peers in the same neighborhood.